Pharmalot Ed Silverman STAT Plus: Mark Cuban teams with a business coalition in bid to lower drug costs for employers
Pharmalot Ed Silverman STAT Plus: A year after petition, NIH will finally review request to lower cancer drug’s cost by sidestepping patents
Politics Eric Boodman STAT Plus: Chelsea Clinton on abortion care and the connection between democracy and women’s health
Health Eric Boodman Legal at one clinic, illegal at another: How abortion bans make gestational age even less precise
Pharmalot Ed Silverman STAT Plus: Amid concerns over U.S. democracy, pharma helped finance committees that support election deniers
Politics STAT Staff STAT Plus: Health and science are on the ballot this election. Here’s what we’re watching
Pharmalot Ed Silverman STAT Plus: A ‘blank check’: Bill to boost antibiotic development blasted as a ‘flawed’ giveaway to pharma
Pharmalot Ed Silverman STAT Plus: Senate lawmakers introduce a bill to help the FDA and the U.S. Patent Office coordinate
Pharmalot Ed Silverman and John Wilkerson STAT Plus: Pallone pushes NIH and FDA to disclose steps being taken to ensure clinical trial results are reported
Politics Sarah Owermohle Still fuming over the federal Covid response, Republicans redirect the House coronavirus committee
Politics Nicholas Florko STAT Plus: Audit of FDA’s tobacco oversight underscores agency’s struggle to regulate the booming vaping market
Pharmalot Ed Silverman STAT Plus: After years of lax oversight, the NIH is starting to contact institutions about unreported clinical trial results
Pharmalot Ed Silverman STAT Plus: Lawmakers ask GAO to probe pharmacy benefit managers over their role in drug pricing
Pharmalot Ed Silverman STAT Plus: Lawmakers and PhRMA trade accusations of ‘misleading’ information on drug price hikes
Pharmalot Ed Silverman STAT Plus: Watchdog says Lilly made ‘false assertions’ about impact of pausing political donations after Jan. 6 attack
Pharmalot Ed Silverman STAT Plus: Some drug makers quietly resumed donations to lawmakers who denied Biden’s election victory
Exclusive Nicholas Florko STAT Plus: Abandoned Trump order on the bioeconomy highlights a path forward for Biden — but with mixed reviews
Pharmalot Ed Silverman STAT Plus: Pfizer shareholders are urged to reject political spending that contradicts ‘company values’
The Pharmalot View Ed Silverman Oh, the irony! Trump may like to vilify drug makers, but now he needs them more than ever
Politics Lev Facher STAT Plus: Q&A: Vivek Murthy, a top Biden adviser, on Covid-19 vaccines, the drug industry, and the future of public health
Politics Lev Facher A Senate race in Kansas between two doctors sets the stage for an election hyper-focused on health policy — and on Covid-19
Special Report Lev Facher Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
Politics Lev Facher Trump urges people to avoid discretionary travel and limit gatherings to fewer than 10 people
Politics Lev Facher Elbow bumps, social distancing, and Medicare for All: The coronavirus pandemic dominated every aspect of the Democratic debate
Politics Lev Facher STAT Plus: ‘Reject Big Pharma’: Anti-vaccine activists co-opt a populist slogan to try to repeal a state immunization law
Politics Andrew Joseph STAT Plus: In their words: Warren, Buttigieg, Klobuchar, and other Democrats explain exactly how they’d lower drug prices
Off the Charts Jennifer Adaeze Okwerekwu As medical professionals, my husband and I know the Nigerian travel ban is cruel. Now the pain is personal
Politics Nicholas Florko STAT Plus: More than a dozen Democrats are bringing people with sky-high insulin bills to the State of the Union
Politics Lev Facher STAT Plus: House Republicans fuel Capitol Hill chaos with competing drug pricing bill